Stocks · Korea 000230 KOSPI

Ildong Holdings

6,270원 +0.16% Market cap 724억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER6.48x
PBR0.43x
EPS967 KRW
BPS14,623 KRW
ROE9.36%
DPS100 KRW

Returns and 52-week range

1W+5.56%
1M-0.48%
3M-1.88%
6M-38.83%
1Y-35.56%
YTD-52.86%
52W high17,170원
52W low5,450원
From 52W high-63.48%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20226,755억-984억-1,945억-14.6%
20236,384억-796억-1,188억-12.5%
20246,576억-24억556억-0.4%
20255,909억149억216억2.5%
Quarterly
2024 4Q1,663억46억832억2.8%
2025 1Q1,498억41억-52억2.7%
2025 2Q1,488억-20억-86억-1.3%
2025 3Q1,505억65억151억4.3%
2025 4Q1,418억63억204억4.4%
2026 1Q1,489억89억58억6.0%

Company

CEO최규환
Founded1941-03-14
Fiscal year end12
Address: 서울특별시 서초구 바우뫼로27길 2 일동제약빌딩

Peers in the same sector

CompanyMarket capP/EP/B1M
씨티씨바이오730억22.210.99-1.31%
HLB제넥스710억2.811.55+11.69%
휴마시스770억—0.33-2.95%
신신제약702억7.550.94+1.32%
신일제약783억10.030.50+9.63%
애드바이오텍688억—2.36-8.95%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.